Nike falls as revenue miss overshadows earnings beat

Nike reported fiscal Q1 adjusted EPS of $0.48, beating the $0.44 consensus, but revenue missed estimates at $11.21B versus $11.35B and declined 5% year over year on a currency-neutral basis. Weakness was broad-based, including an 8% drop in Nike Direct revenue and declines in Greater China and EMEA, while gross margin rose 60bps to 42.8% on lower logistics costs. Nike expects fiscal 2027 revenue to fall by high-single digits and EPS of $1.15-$1.35 excluding roughly $0.15 of restructuring costs, alongside a Pace restructuring intended to deliver $2.5B in cumulative savings through fiscal 2031.

Analysis

The key equity issue is not the modest margin repair but whether Nike can arrest brand and channel share loss before fixed-cost deleverage overwhelms the savings program. Cost actions can protect near-term EPS, but they are a poor substitute for full-price sell-through: sustained weakness in lifestyle, Jordan and direct channels would force incremental wholesale promotions, impairing both gross margin and brand heat. DECK, ONON and SKX are the most plausible listed share recipients in premium running, performance and accessible footwear; wholesale partners such as FL also gain bargaining power if Nike needs distribution normalization.

The market is likely to focus on the headline savings target, but its value is back-end loaded while restructuring charges and revenue pressure are front-loaded. Over the next 1-3 months, the catalyst path is negative: channel inventory commentary, holiday sell-through and China demand data can trigger further estimate cuts. Over 6-18 months, the stock can rerate only if reported revenue stabilizes before deeper discounting appears; otherwise, a lower earnings base and diminished brand premium justify multiple compression. Elevated short interest makes an outright short unattractive after a sharp decline: a credible China stabilization or direct-channel inflection could generate a violent tactical squeeze even without a durable turnaround.

Contrarian case: expectations may now be low enough that clean inventory, easier comparisons and supply-chain savings produce repeated EPS beats. That is not yet a long thesis unless revenue quality improves—specifically, growth in full-price footwear and direct sales rather than savings-led margin expansion. The structural risk to bears is that Nike's scale in athlete marketing and wholesale shelf allocation can reassert itself faster than smaller challengers can fund demand creation.

Key Decisions for Investors

• Maintain an underweight in NKE for the next 1-3 months, but do not chase the post-results move. Prefer buying 3- to 6-month put spreads on a relief rally; this limits short-squeeze risk while retaining exposure to the next guidance-reset or holiday sell-through catalyst.
• Run a relative-value basket: long SKX and/or ONON versus short NKE over 3-6 months, sized modestly because ONON carries material valuation risk. The thesis is relative share capture in performance footwear; exit if Nike demonstrates sequential improvement in direct sales and Greater China without a corresponding rise in promotional activity.
• Avoid treating the multiyear cost program as incremental operating leverage until management quantifies annual savings realization and separates permanent savings from supply-chain normalization. Set an alert for a fiscal-year EPS outlook reduction or evidence that restructuring charges exceed the planned run rate; either would support adding to NKE downside exposure.
• For a turnaround entry, wait for two conditions: revenue decline materially narrows for two consecutive quarters and gross margin holds without elevated markdowns. If those occur, cover NKE shorts first rather than immediately going long; the likely initial move would be multiple expansion driven by short covering, not yet durable earnings growth.